Your Article Summary
See Latest ArticlesBurkitt Lymphoma in Children: The Israeli Experience
Journal of Pediatric Hematology/Oncology, 07/02/09
Eldar AH et al. - In nonresected mature B-cell lymphoma of childhood and adolescence with no BM or CNS involvement, a 93% cure rate can be achieved, similar to the French-American-British/LMB 96 trial. Patients with primary DLBC mediastinal mass had a significantly reduced OS, indicating the need for a different therapeutic approach.
Related Articles
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
Hematological Oncology, 10/27/09
Relevance Score: 70%
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Childrens Oncology Group study CCG-5961
British Journal of Haematology, 11/11/09
Relevance Score: 68%
c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma
Oncogene, 11/05/09
Relevance Score: 68%
Treatment-Related Burkitt's Lymphoma: Literature Review and Case Report of Successful Treatment with Rituximab Monotherapy
Acta Haematologica, 11/04/09
Relevance Score: 67%
Tumor lysis and acute renal failure in Burkitt's lymphoma: A review on pathophysiology and management
Indian Journal of Nephrology, 10/16/09
Relevance Score: 66%
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Risk Factors Associated With Deformational Plagiocephaly
Pediatrics, 12/11/09
Continuous Monitoring of Cerebrovascular Pressure Reactivity After Traumatic Brain Injury in Children
Pediatrics, 12/11/09